Molecular Mechanism of SSR128129E, an Extracellularly Acting, Small-Molecule, Allosteric Inhibitor of FGF Receptor Signaling
- Herbert, Corentin
- Schieborr, Ulrich
- Saxena, Krishna
- Juraszek, Jarek
- De Smet, Frederik
- Alcouffe, Chantal
- Bianciotto, Marc
- Saladino, Giorgio
- Sibrac, David
- Kudlinzki, Denis
- Sreeramulu, Sridhar
- Brown, Alan
- Rigon, Patrice
- Herault, Jean-Pascal
- Lassalle, Gilbert
- Blundell, Tom L.
- Rousseau, Frederic
- Gils, Ann
- Schymkowitz, Joost
- Tompa, Peter
- Herbert, Jean-Marc
- Carmeliet, Peter
- Gervasio, Francesco Luigi
- Schwalbe, Harald
- Bono, Françoise
DOIAbstract
SummaryThe fibroblast growth factor (FGF)/fibroblast growth factor receptor (FGFR) signaling network plays an important role in cell growth, survival, differentiation, and angiogenesis. Deregulation of FGFR signaling can lead to cancer development. Here, we report an FGFR inhibitor, SSR128129E (SSR), that binds to the extracellular part of the receptor. SSR does not compete with FGF for binding to FGFR but inhibits FGF-induced signaling linked to FGFR internalization in an allosteric manner, as shown by crystallography studies, nuclear magnetic resonance, Fourier transform infrared spectroscopy, molecular dynamics simulations, free energy calculations, structure-activity relationship analysis, and FGFR mutagenesis. Overall, SSR is a small m...
Add to ORKG